Jennison Associates’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,243,995
| Closed | -$14.7M | – | 687 |
|
|
2017
Q3 | $14.7M | Sell |
1,243,995
-106,886
| -8% | -$1.27M | 0.02% | 441 |
|
|
2017
Q2 | $13.6M | Sell |
1,350,881
-25,412
| -2% | -$255K | 0.01% | 449 |
|
|
2017
Q1 | $16M | Buy |
+1,376,293
| New | +$16M | 0.02% | 444 |
|
|
2014
Q4 | – | Sell |
-409,409
| Closed | -$4.37M | – | 751 |
|
|
2014
Q3 | $4.37M | Buy |
409,409
+612
| +0.1% | +$6.53K | ﹤0.01% | 506 |
|
|
2014
Q2 | $3.84M | Sell |
408,797
-48,009
| -11% | -$451K | ﹤0.01% | 511 |
|
|
2014
Q1 | $3.15M | Buy |
456,806
+1,535
| +0.3% | +$10.6K | ﹤0.01% | 546 |
|
|
2013
Q4 | $1.78M | Sell |
455,271
-1,083,831
| -70% | -$4.23M | ﹤0.01% | 568 |
|
|
2013
Q3 | $7.83M | Buy |
1,539,102
+871,432
| +131% | +$4.44M | 0.01% | 485 |
|
|
2013
Q2 | $4.27M | Buy |
+667,670
| New | +$4.27M | ﹤0.01% | 490 |
|